Clement Popovici joined Reistone in 2020 as Executive Director, Head of International Clinical Operations. He has over 20 years of experience in the pharmaceutical industry focused in the Clinical Operations area.
Clement spent 18 years at Takeda Pharmaceuticals in various Clinical Operations roles of increasing responsibility across numerous therapeutic areas, lastly as Senior Director Clinical Operations of Neuroscience and Marketed Products. He has experience in providing global leadership in the planning and execution of clinical studies across all phases of development. Most recently prior to joining Reistone, Clement supported the Global Clinical Development team at Baxter Healthcare. His focus was on process improvements and systems, in addition to initiating activities for post-marketing clinical studies to enable compliance with the new requirements of the EU Medical Device Regulations.
Clement received his Masters in Biotechnology from Northwestern University and Bachelors in Chemistry from the University of Chicago.